Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract with increasing incidence worldwide. Although a deeper understanding of the underlying mechanisms of IBD has led to new therapeutic approaches, treatment options are still limited. Severe adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Ries, Markus, Moulari, Brice, Shetab Boushehri, Maryam A., Ali, Mohamed Ehab, Molnar, Daniel, Béduneau, Arnaud, Pellequer, Yann, Lamprecht, Alf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879121/
https://www.ncbi.nlm.nih.gov/pubmed/35214083
http://dx.doi.org/10.3390/pharmaceutics14020352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879121/
https://www.ncbi.nlm.nih.gov/pubmed/35214083
http://dx.doi.org/10.3390/pharmaceutics14020352

Ejemplares similares